Tower Research Capital LLC (TRC) - NEPHROGENEX INC ownership

NEPHROGENEX INC's ticker is NRXGQ and the CUSIP is 640667101. A total of 13 filers reported holding NEPHROGENEX INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of NEPHROGENEX INC
ValueSharesWeighting
Q4 2015$10,000
+900.0%
6,179
+2989.5%
0.00%
Q2 2015$1,0000.0%200
+100.0%
0.00%
Q1 2015$1,000
-75.0%
100
-87.5%
0.00%
Q3 2014$4,000
-69.2%
800
-61.1%
0.00%
-100.0%
Q2 2014$13,000
-27.8%
2,056
-8.8%
0.00%0.0%
Q1 2014$18,0002,2550.00%
Other shareholders
NEPHROGENEX INC shareholders Q1 2015
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 1,326,826$6,210,0003.12%
Knoll Capital Management, LLC 50,000$234,0000.09%
FIRST NEW YORK SECURITIES LLC /NY 24,314$113,790,0000.08%
LMR Partners LLP 147,250$689,0000.06%
Visium Asset Management, LP 477,000$2,232,0000.03%
First Western Capital Management Co 13,100$61,0000.02%
STONERIDGE INVESTMENT PARTNERS LLC 19,125$90,0000.01%
Ground Swell Capital, LLC 756$4,0000.01%
UBS AG 1,466$7,0000.00%
BANK OF AMERICA CORP /DE/ 9,100$43,0000.00%
View complete list of NEPHROGENEX INC shareholders